WETTIG THANE (Chief Commercial Officer) reported 1 transaction at KYNTRA BIO, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/10/2026ACC: 0001815638-26-000003
Officer· Chief Commercial Officer
Since Jun 2020
-277.00
Net shares
Net seller
$1.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
277.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−277.00
Price / share
$6.84
Trade value
$1.89K
% of position
1.1%
3/6/2026
24.68K→24.40K
Total
Net shares
−277.00
Net value
-$1.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/6/2026 | F · Tax Withholding | −277.00 | $6.84 | $1.89K | 1.1% | 24.68K | 24.40K |
| Total | −277.00 | -$1.89K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned40.00
Total
40.00 indirect40.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40.00 | Indirect |
| Total | 40.00 | 40.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported